Lung microbiome alterations in patients with anti-Jo1 antisynthetase syndrome and interstitial lung disease

被引:1
|
作者
Quintero-Puerta, Teresa [1 ]
Lira-Lucio, Juan Alberto [1 ]
Falfan-Valencia, Ramces [1 ]
Vega-Sanchez, Angel E. [2 ]
Marquez-Garcia, Eduardo [3 ]
Mejia, Mayra [2 ]
Bautista-Becerril, Brandon [1 ]
Rojas-Serrano, Jorge [2 ]
Ramos-Martinez, Espiridion [4 ]
Buendia-Roldan, Ivette [5 ]
Perez-Rubio, Gloria [1 ]
机构
[1] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, HLA Lab, Mexico City, Mexico
[2] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Interstitial Lung Dis & Rheumatol Unit, Mexico City, Mexico
[3] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Subdirecc Invest Biomed, Mexico City, Mexico
[4] Univ Nacl Autonoma Mexico, Fac Med, Expt Med Res Unit, Mexico City, Mexico
[5] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Lab Translat Res Aging & Pulm, Mexico City, Mexico
关键词
lung microbiome; 16S ribosomal subunit; antisynthetase syndrome; interstitial lung disease; Veillonella; CHAIN FATTY-ACIDS; CLINICAL-FEATURES; FIBROSIS; COHORT;
D O I
10.3389/fcimb.2023.1321315
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Aim: To characterize the lung microbiome in the bronchoalveolar lavage fluid (BALF) of patients with Antisynthetase Syndrome (ASSD) according to anti-Jo1 autoantibody positivity and evaluate the correlation with differential cell count and other bacterial genera in BALF.Methods: We sequenced the 16S ribosomal RNA gene in the BALF of anti-Jo1-positive (JoP, n=6) and non-Jo1-positive (NJo, n=17) patients, and the differential cell count in BALF was evaluated. The Spearman's correlation was calculated for the quantitative variables and abundance of bacterial species.Results: The Veillonella genus showed a significant decrease (p<0.01) in JoP (2.2%) in comparison to NJo (4.1%) patients. The correlation analysis showed several high (rho >= +/- 0.7) and significant (p < 0.05) correlations. We analyzed the results obtained for the Veillonella genera and other study variables. The JoP group showed that the abundance of Veillonella had a high negative correlation with macrophages (rho = - 0.77) and a positive correlation with eosinophils (rho = 0.77), lymphocytes (rho = 0.77), and Prevotella (rho = 1).Conclusions: The lung microbiome in ASSD patients differs and may affect cell composition, contributing to lung damage mechanisms. The presence of anti-Jo1 autoantibodies showed a low abundance of Veillonella. This genus had a strong and positive correlation with Prevotella abundance and levels of eosinophils and lymphocytes, and it showed a strong negative correlation with the percentage of macrophages.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] AUTOIMMUNE AFFLICTIONS: A CASE OF INTERSTITIAL LUNG DISEASE AND ANTISYNTHETASE SYNDROME
    Vattem, Nishita
    Patel, Rahul
    Kata, Vijay
    Mayer, Nancy
    Singh, Sasha
    Vora, Irfan
    Joshi, Dhruv
    Sibai, Firas
    Khanna, Samrat
    Almeida, Roselle
    CHEST, 2024, 166 (04) : 3389A - 3390A
  • [42] Treatment in Antisynthetase Syndrome-Associated Interstitial Lung Disease
    JA Huapaya
    KD Wiley
    SK Danoff
    Current Treatment Options in Rheumatology, 2021, 7 : 243 - 257
  • [43] ANTISYNTHETASE SYNDROME PRESENTING AS RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE
    Brewster, Nathan
    Joshi, Amogh
    Kears, Alaynna
    Godil, Kareem
    Boehmler, Jessica
    Zirlinger, Andres
    CHEST, 2019, 156 (04) : 1409A - 1409A
  • [44] A CASE OF INTERSTITIAL LUNG DISEASE AS A PRESENTING FEATURE OF ANTISYNTHETASE SYNDROME
    Eneh, Chukwuka
    Nevolina, Anna
    Kozii, Khrystyna
    Ogbonda, Stephanie
    Khapov, Ivan
    Niiranen, Jussi
    Aktas, Suat
    CHEST, 2024, 166 (04) : 5569A - 5570A
  • [45] POLYARTHRITIS AND INTERSTITIAL LUNG DISEASE: ANTISYNTHETASE SYNDROME: A MURKY DIAGNOSIS
    Siraj, Khaja
    CHEST, 2019, 156 (04) : 1567A - 1567A
  • [46] A Review of Antisynthetase Syndrome-Associated Interstitial Lung Disease
    Patel, Puja
    Marinock, Jenna M.
    Ajmeri, Aamir
    Brent, Lawrence H.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (08)
  • [47] Treatment in Antisynthetase Syndrome-Associated Interstitial Lung Disease
    Huapaya, J. A.
    Wiley, K. D.
    Danoff, S. K.
    CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2021, 7 (03) : 243 - 257
  • [48] Antisynthetase syndrome presenting as interstitial lung disease: a case report
    Badshah, Aliena
    Haider, Iqbal
    Pervez, Shayan
    Humayun, Mohammad
    JOURNAL OF MEDICAL CASE REPORTS, 2019, 13 (01)
  • [49] Cyclophosphamide For Antisynthetase Syndrome-Associated Interstitial Lung Disease
    Huapaya, J. A.
    Silhan, L. L.
    Danoff, S. K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [50] Antisynthetase syndrome presenting as interstitial lung disease: a case report
    Aliena Badshah
    Iqbal Haider
    Shayan Pervez
    Mohammad Humayun
    Journal of Medical Case Reports, 13